Phthalylsulfathiazole Market

Phthalylsulfathiazole Market Size, Share & Industry Analysis, By Source (Pharmaceutical Manufacturers (Branded & Generic), Contract Manufacturing Organizations (CMOs), Research-Grade Suppliers) By End-User (Pharmaceutical Industry, Hospitals & Clinics, Research Institutions) and Forecast, 2025-2035

The Phthalylsulfathiazole market is projected to grow at a CAGR of 3.8% from 2025 to 2035, driven by the continued need for effective antimicrobial agents, particularly in gastrointestinal infections caused by bacteria. Phthalylsulfathiazole is a sulfonamide antimicrobial compound that exerts its action by inhibiting the synthesis of folic acid in bacterial cells, which is essential for their growth and replication. It is primarily used in the treatment of enteric infections such as gastroenteritis and diarrhea caused by Salmonella and Shigella species.

Phthalylsulfathiazole is typically administered in the oral form and is recognized for its broad-spectrum activity against a range of gram-positive and gram-negative bacteria. While it has been largely replaced by more modern antibiotics in some regions, it remains an important treatment option in areas where infections are prevalent, and other treatments are not readily available or affordable.

Asia-Pacific is expected to witness the highest growth rate, driven by the high prevalence of bacterial gastrointestinal infections and the increasing need for affordable treatment options. Africa and Latin America also represent key markets, where enteric diseases are a significant public health concern. Europe and North America show stable demand, primarily in pediatric formulations and in emergency treatments, although newer antibiotics have somewhat reduced the market for traditional sulfonamides

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Phthalylsulfathiazole
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Source
    • Pharmaceutical Manufacturers (Branded & Generic)
    • Contract Manufacturing Organizations (CMOs)
    • Research-Grade Suppliers
  • Key End-Use Industries
    • Pharmaceutical Industry.
    • Hospitals & Clinics.
    • Research Institutions.
  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America, Middle East, and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  • Laboratorium Ofichem B.V.
  • ZellBio GmbH
  • Chem-Impex International
  • InvivoChem
  • Selleck Chemicals
  • TCI Chemicals (India) Pvt. Ltd.
  • Chemball
  • Pharmacompass
  • chemBlink
  • Tokyo Chemical Industry Co., Ltd. (TCI)
  • Sigma-Aldrich (Merck)
  • Alfa Aesar (Thermo Fisher Scientific)
  • Acros Organics (Thermo Fisher Scientific)
  • Santa Cruz Biotechnology
  • Cayman Chemical
  • BioVision
  • Enzo Life Sciences
  • Toronto Research Chemicals (TRC)
  • ChemSpider
  • PubChem
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies
What is Phthalylsulfathiazole?
Phthalylsulfathiazole is a synthetic sulfonamide antibiotic primarily used for the treatment of gastrointestinal infections, particularly those caused by certain bacteria. It works by inhibiting the synthesis of folic acid in bacteria.
What is the market growth of Phthalylsulfathiazole?
The global market for phthalylsulfathiazole is expected to grow at a modest CAGR of 3.8% from 2025 to 2035. This slow growth can be attributed to the declining use of traditional sulfonamide antibiotics due to the development of newer, more effective antibiotics with fewer side effects.
What are the drivers of the Phthalylsulfathiazole market?
The main drivers of the phthalylsulfathiazole market include the ongoing need for effective treatments for gastrointestinal bacterial infections, particularly in regions where access to newer antibiotics is limited.
Who are the key players operating in the Phthalylsulfathiazole market?
Key players in the phthalylsulfathiazole market include pharmaceutical companies that specialize in the production of generic antibiotics. Companies such as Mylan, Teva Pharmaceuticals, and Sandoz are involved in the production and distribution of older antibiotic formulations like phthalylsulfathiazole.
Which region will exhibit the fastest growth in the Phthalylsulfathiazole market?
The Asia-Pacific region is expected to exhibit the fastest growth in the phthalylsulfathiazole market. The ongoing prevalence of gastrointestinal infections, combined with the high levels of antibiotic resistance, contributes to the demand for older antibiotics like phthalylsulfathiazole.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.